newsfilter
← Latest News
PR Newswire·

Acquisition of Fusion Pharmaceuticals Completed

Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs), announced...